ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 42 filers reported holding ACUMEN PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,293 | +25.2% | 22,239 | +45.1% | 0.00% | – |
| Q2 2023 | $73,710 | -64.8% | 15,324 | -70.2% | 0.00% | – |
| Q1 2023 | $209,123 | +50.8% | 51,508 | +100.5% | 0.00% | – |
| Q4 2022 | $138,693 | -26.6% | 25,684 | +35.8% | 0.00% | – |
| Q3 2022 | $189,000 | +65.8% | 18,914 | -21.8% | 0.00% | – |
| Q2 2022 | $114,000 | +115.1% | 24,197 | +76.8% | 0.00% | – |
| Q1 2022 | $53,000 | -61.9% | 13,687 | -33.7% | 0.00% | – |
| Q4 2021 | $139,000 | +1637.5% | 20,633 | +3526.2% | 0.00% | – |
| Q3 2021 | $8,000 | – | 569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $14,180,861 | 4.20% |
| Knollwood Investment Advisory, LLC | 1,628,510 | $6,758,317 | 3.16% |
| Altium Capital Management LP | 650,000 | $2,697,500 | 1.41% |
| RA Capital Management | 14,932,063 | $61,968,061 | 1.22% |
| GREAT POINT PARTNERS LLC | 1,074,101 | $4,457,519 | 0.81% |
| Boxer Capital, LLC | 2,206,983 | $9,158,979 | 0.49% |
| Deep Track Capital, LP | 2,513,044 | $10,429,133 | 0.40% |
| Parkman Healthcare Partners LLC | 499,814 | $2,074,228 | 0.38% |
| Rock Springs Capital Management LP | 2,812,579 | $11,672,203 | 0.31% |
| Ghost Tree Capital, LLC | 150,000 | $622,500 | 0.20% |